Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
Am J Clin Pathol
    May 2018
  1. LANDMANN A, Farrugia DJ, Zhu L, Diego EJ, et al
    Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?
    Am J Clin Pathol. 2018 May 8. pii: 4993844. doi: 10.1093.
    >> Share

    February 2018
  2. CLARK BZ, Farrugia DJ, Landmann A, Diego EJ, et al
    Prognostic Significance of Modified Residual Disease in Breast and Nodes (mRDBN) Algorithm After Neoadjuvant Chemotherapy for Breast Cancer.
    Am J Clin Pathol. 2018 Feb 22. pii: 4899077. doi: 10.1093.
    >> Share

    Delay to Formalin Fixation (Cold Ischemia Time) Effect on Breast Cancer Molecules.
    Am J Clin Pathol. 2018 Feb 19. pii: 4874188. doi: 10.1093.
    >> Share

    November 2017
  4. SHIN ET, Joehlin-Price AS, Agnese DM, Zynger DL, et al
    Minimal Clinical Impact of Intraoperative Examination of Sentinel Lymph Nodes in Patients With Ductal Carcinoma In Situ: An Opportunity for Improved Resource Utilization.
    Am J Clin Pathol. 2017;148:374-379.
    >> Share

    October 2017
    Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference Laboratory.
    Am J Clin Pathol. 2017;148:308-313.
    >> Share

    September 2017
  6. LIN CY, Carneal EE, Lichtensztajn DY, Gomez SL, et al
    Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks.
    Am J Clin Pathol. 2017;148:199-207.
    >> Share

  7. KUBA MG, Lester SC, Giess CS, Bertagnolli MM, et al
    Fibromatosis of the Breast: Diagnostic Accuracy of Core Needle Biopsy.
    Am J Clin Pathol. 2017;148:243-250.
    >> Share

    August 2017
  8. KHOURY T, Zirpoli G, Cohen SM, Geradts J, et al
    Ki-67 Expression in Breast Cancer Tissue Microarrays: Assessing Tumor Heterogeneity, Concordance With Full Section, and Scoring Methods.
    Am J Clin Pathol. 2017;148:108-118.
    >> Share

  9. HOU Y, Zynger DL, Li X, Li Z, et al
    Comparison of Oncotype DX With Modified Magee Equation Recurrence Scores in Low-Grade Invasive Carcinoma of Breast.
    Am J Clin Pathol. 2017;148:167-172.
    >> Share

    April 2017
  10. BHARGAVA R, Florea AV, Pelmus M, Jones MW, et al
    Breast Tumor Resembling Tall Cell Variant of Papillary Thyroid Carcinoma: A Solid Papillary Neoplasm With Characteristic Immunohistochemical Profile and Few Recurrent Mutations.
    Am J Clin Pathol. 2017;147:399-410.
    >> Share

    March 2017
  11. SOLOMON JP, Dell'Aquila M, Fadare O, Hasteh F, et al
    Her2/neu Status Determination in Breast Cancer: A Single Institutional Experience Using a Dual-Testing Approach With Immunohistochemistry and Fluorescence In Situ Hybridization.
    Am J Clin Pathol. 2017 Mar 11. doi: 10.1093.
    >> Share

  12. LIN D, Genzen J
    Comparison of Breast Cancer Tumor Marker Test Results: A Retrospective Analysis of Paired CA 15-3 and CA 27.29 Testing at a National Reference Laboratory.
    Am J Clin Pathol. 2017 Mar 1. doi: 10.1093.
    >> Share

    January 2017
  13. SERDY KM, Leone JP, Dabbs DJ, Bhargava R, et al
    Male Breast Cancer: A Single-Institution Clinicopathologic and Immunohistochemical Study.
    Am J Clin Pathol. 2017 Jan 24. pii: aqw207. doi: 10.1093.
    >> Share

  14. HOU Y, Nitta H, Li Z
    HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer.
    Am J Clin Pathol. 2017 Jan 21. pii: aqw211. doi: 10.1093.
    >> Share

  15. SERDY KM, Leone JP, Dabbs DJ, Bhargava R, et al
    Male Breast Cancer.
    Am J Clin Pathol. 2017;147:110-119.
    >> Share

    October 2016
  16. SHEN T, Zhang K, Siegal GP, Wei S, et al
    Prognostic Value of E-Cadherin and beta-Catenin in Triple-Negative Breast Cancer.
    Am J Clin Pathol. 2016.
    >> Share

  17. LI X, Wetherilt CS, Krishnamurti U, Yang J, et al
    Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer.
    Am J Clin Pathol. 2016;146:496-502.
    >> Share

    September 2016
  18. SHAO T, Wood M, Wing A, Hnatovska M, et al
    Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer: A Cohort Study Emphasizing Equivocal Cases.
    Am J Clin Pathol. 2016;146:339-45.
    >> Share

    June 2016
  19. LI XB, Krishnamurti U, Bhattarai S, Klimov S, et al
    Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Am J Clin Pathol. 2016.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016